Associated Papers
The pharmacogenomic landscape in the Chinese: An analytics of pharmacogenetic variants in 206,640 individuals.
Wang LY et al.
Innovation (cambridge (mass.)), 2025
39991480 (PubMed )
Supplement: mmc5.xlsx › Sheet1
Genetic variations and recurrence in stage III Korean colorectal cancer: Insights from tumor-only mutation analysis.
Jeon H et al.
Plos One, 2025
40408428 (PubMed )
Supplement: pone.0323302.s003.xlsx › Sheet1
Compound heterozygous WNT10A missense variations exacerbated the tooth agenesis caused by hypohidrotic ectodermal dysplasia.
Liu Y et al.
Bmc Oral Health, 2024
38280992 (PubMed )
Supplement: 12903_2024_3888_MOESM2_ESM.xls › Supplementary_Table_1
A kinase-dead natural polymorphism in the canine Tnni3k gene.
Westbury BC et al.
Micropublication Biology, 2024
Expression Levels of the Tnni3k Gene in the Heart Are Highly Associated with Cardiac and Glucose Metabolism-Related Phenotypes and Functional Pathways.
Gu Q et al.
International Journal of Molecular Sciences, 2023
Rare Compound Heterozygous Missense Mutation of the SCN5A Gene with Childhood-Onset Sick Sinus Syndrome in Two Chinese Sisters.
Wang Y et al.
International Heart Journal, 2023
The Diverse Roles of TNNI3K in Cardiac Disease and Potential for Treatment.
Pham C et al.
International Journal of Molecular Sciences, 2021
The prevalent I686T human variant and loss-of-function mutations in the cardiomyocyte-specific kinase gene TNNI3K cause adverse contractility and concentric remodeling in mice.
Gan P et al.
Human Molecular Genetics, 2021
Tnni3k alleles influence ventricular mononuclear diploid cardiomyocyte frequency.
Gan P et al.
Plos Genetics, 2019
Patient-derived glioblastoma organoids reflect tumor heterogeneity and treatment sensitivity.
Verduin M et al.
Neuro-oncology Advances, 0
38130902 (PubMed )
Supplement: vdad152_suppl_supplementary_materials_5.xlsx › SNVs
Select a paper to view details